Electromed Releases SmartVest Clearway to Hospital Market

Electromed Inc. has officially launched the SmartVest Clearway Airway Clearance System to the hospital market for inpatient use.

The SmartVest Clearway system, designed for high frequency chest wall oscillation (HFCWO) therapy, offers an updated and efficient approach to pulmonary hygiene in the inpatient setting with proven patient outcomes.¹
 
The SmartVest Clearway system uses HFCWO, a clinically proven therapy that helps clear the lungs of excess secretions, thereby reducing the risk of respiratory infections.¹ HFCWO delivers alternating pulses of air into a vest garment that rapidly compresses and releases the chest wall, resulting in an oscillation in airflow within the airways that acts to loosen, thin, and propel mucus toward the major airways where it can be expectorated.
 
“SmartVest Clearway provides therapeutic relief for patients suffering from ineffective secretion clearance due to muscle weakness, ineffective cough, or impaired ventilation. The intuitive system is designed to help hospital staff speed patient recovery for patients with dysfunctional airway clearance,” Electromed President/CEO Jim Cunniff said. “We are proud to further our mission in assisting more patients to breathe easier, improve their quality of life, and prevent hospital readmissions.”
 
Electromed manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System, to patients with compromised pulmonary function. It is headquartered in New Prague, Minn., and was founded in 1992. 

Reference 
¹ Sievert CE, et al. 2016. Respiratory Therapy, 11(4), 34–38.